Resume. The article describes the experience of the early use of Xavron (Edaravon) in patients with ischemic stroke in combination with thrombolytic therapy (TLT). These studies indicate greater efficacy of using Edaravon in combination with TLT in the treatment of ischemic stroke. When using the drug Xavron side effects of the drug was not observed.

Keywords: comprehensive treatment; edaravone

Authors: O.B. Leskiv, T.F. Khabaznia

Posted: THE JOURNAL OF NEUROSCIENCE of B.M. Mankovskyi’ 2019, ТОМ 7, № 3-4